FDA: ANDA Submissions—Amendments to ANDAs Under GDFUA [BE/BA News]

posted by Helmut Homepage – Vienna, Austria, 2018-08-09 10:52 (983 d 12:54 ago) – Posting: # 19161
Views: 1,594

Dear all,

a new Guidance for Industry

ANDA Submissions—Amendments to Abbreviated New Drug Applications Under GDUFA

was published in the Federal Register on July 5th.
See esp. APPENDIX A: MAJOR DEFICIENCIES, B. Bioequivalence Deficiencies.

Dif-tor heh smusma 🖖
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

Activity
 Admin contact
21,419 posts in 4,475 threads, 1,509 registered users;
online 16 (0 registered, 16 guests [including 5 identified bots]).
Forum time: Sunday 23:46 CEST (Europe/Vienna)

Nothing fails like success because you do not learn anything from it.
The only thing we ever learn from is failure.
Success only confirms our superstitions.    Kenneth E. Boulding

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5